Bio-Path Holdings
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us

Webcast link to Third Quarter 2024 Financial Results Conference Call – Friday, November 15, 2024 at 8:30 a.m. ET

Webcast link to the H.C. Wainwright 26th Annual Global Investment Conference – Monday, September 9, 2024 at 7:00 a.m. ET.

Webcast link to Second Quarter 2024 Financial Results Conference Call – Thursday, August 15, 2024 at 8:30 a.m. ET

Webcast link to First Quarter 2024 Financial Results Conference Call – Wednesday, May 15, 2023 at 8:30 a.m. ET

Webcast Link to Fourth Quarter and Full Year for period ended December 31, 2023 on Friday, March 8, 2024 at 8:30 a.m. ET

Webcast Link to H.C. Wainwright 25th Annual Global Investment Conference – Tuesday. September 12, 2023

Webcast link to First Quarter 2023 Financial Results Conference Call – Friday, May 12. 2023 at 8:30 a.m. ET

Webcast link to Fourth Quarter and Full Year 2022 Financial Results Conference Call – Friday, March 31. 2023 at 8:30 a.m. ET

Webcast Link to Third Quarter 2022 Earnings Financial Results Conference Call – Tuesday November 15, 2022 at 8:30 a.m. ET

Webcast link to H.C. Wainwright 24th Annual Global Investment Conference – Monday, September 12, 2022 at 7:00 am ET

Bio-Path Holdings

All Rights Reserved

Office:

4710 Bellaire Blvd, Suite 210
Bellaire, TX 77401

T: (832) 742-1357

R&D:

5455 Dashwood Street, Suite 300
Bellaire, TX 77401

T: (832) 742-1357

logo
  • About Bio-Path
    • Overview
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnering Opportunities
  • Technology
  • Pipeline
    • Pipeline
    • Prexigebersen
    • BP1001-A
    • BP1002
    • BP1003
  • Patients
  • Investors
    • Overview
    • SEC Filings
    • Corporate Governance
  • Media
    • Press Releases
    • Events
    • Presentations & Publications
  • Careers
  • Contact Us